Prestige Consumer Healthcare (PBH) Capital Expenditures (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Capital Expenditures of $3.0 million for Q4 2025, up 93.36% year-over-year from $1.6 million in Q4 2024, and up 44.05% quarter-over-quarter from $2.1 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Capital Expenditures (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Capital Expenditures history runs 16 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- In Q4 2025, Capital Expenditures rose 93.36% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $9.4 million (up 19.76% YoY), while the FY2025 annual figure was $8.2 million, down 13.88% from the prior year.
- Capital Expenditures for Q4 2025 stood at $3.0 million, up from $2.1 million in the prior quarter.
- The five-year high for Capital Expenditures was $4.9 million in Q1 2021, with the low at $838000.0 in Q2 2025.
- The 5-year median for Capital Expenditures is $2.2 million (2021), against an average of $2.3 million.
- The sharpest annual moves came in 2021 and 2025: Capital Expenditures plunged 69.64% in 2021, then soared 93.36% in 2025.
- Prestige Consumer Healthcare's Capital Expenditures stood at $2.2 million in 2021, then retreated by 19.11% to $1.8 million in 2022, then climbed by 10.7% to $2.0 million in 2023, then declined by 21.54% to $1.6 million in 2024, then jumped by 93.36% to $3.0 million in 2025.
- Business Quant data shows PBH's Capital Expenditures at $3.0 million in Q4 2025, $2.1 million in Q3 2025, and $838000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.03 Mn |
| Dec 31, 2025 | 3.03 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 838,000.00 |
| Jun 30, 2025 | 838,000.00 |
| Mar 31, 2025 | 3.48 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 2.93 Mn |
| Sep 30, 2023 | 2.93 Mn |